Related Experiment Videos

Susan Osborne, DO. Interview by Ina May Gaskin

The Birth Gazette

|January 1, 1994

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours.

ESMO open·2021

Antenatal depression programs cortisol stress reactivity in offspring through increased maternal inflammation and cortisol in pregnancy: The Psychiatry Research and Motherhood - Depression (PRAM-D) Study.

Psychoneuroendocrinology·2018

Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study.

European journal of cancer (Oxford, England : 1990)·2017

Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab).

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Cutaneous immunopathology of long-standing complex regional pain syndrome.

European journal of pain (London, England)·2015

Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer study.

Breast (Edinburgh, Scotland)·2015

See all related articles